Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Oppenheimer Initiates Coverage On PTC with Perform Rating

Oppenheimer Initiates Coverage On PTC with Perform Rating

Oppenheimer analyst Ken Wong initiates coverage on PTC (NASDAQ:PTC) with a Perform rating.

byBenzinga Newsdesk

July 27, 2022

1 minute read

Oppenheimer analyst Ken Wong initiates coverage on PTC (NASDAQ:PTC) with a Perform rating.

Citigroup Maintains Buy on GreenTree Hospitality Gr, Lowers Price Target to $5

By Benzinga Newsdesk

December 29, 7:37 AM

Citigroup analyst Lydia Ling maintains GreenTree Hospitality Gr (NYSE:GHG) with a Buy and lowers the price target from $5.71 to $5.

GHG

Benzinga’s Top Ratings Upgrades, Downgrades For October 12, 2023

By Benzinga Insights

October 12, 11:00 AM

Upgrades According to Craig-Hallum, the prior rating for MasTec Inc (NYSE:MTZ) was changed from Hold to Buy. In…

ALHC

European Union’s Amended COVID-19 Vaccine Deal with Pfizer-BioNTech: Near-Monopoly Status Potential Threat to Rivals

By Vandana Singh

May 1, 8:43 AM

The European Union bloc is reportedly negotiating an amended deal with Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) for around 70 million COVID-19 vaccine doses, despite the European public pro

BNTX

Legal
News

Lucira Health Receives Court Approval For Several Of Its “First Day” Motions

By Happy Mohamed

February 24, 4:52 PM

https://www.docdroid.com/k4kQe6D/lucira-health-first-day-motions-order-1-pdf

LHDX

Oppenheimer Initiates Coverage On PTC with Perform Rating

Related Posts

Citigroup Maintains Buy on GreenTree Hospitality Gr, Lowers Price Target to $5

Benzinga’s Top Ratings Upgrades, Downgrades For October 12, 2023

European Union’s Amended COVID-19 Vaccine Deal with Pfizer-BioNTech: Near-Monopoly Status Potential Threat to Rivals

Lucira Health Receives Court Approval For Several Of Its “First Day” Motions